Newsfeeds - Spark Newswire - Page 3

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

2 minute read

Atossa Genetics Reports Begins Enrollment Of Phase 2 Study Of Oral Endoxifen In Sweden

By Benzinga Newsdesk

Today, 2:11 AM

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current

Read More

2 minute read

Atossa Therapeutics Completes Pre-IND Meeting With FDA On Z-Endoxifen

Today, 2:11 AM

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and infectious disease with a current focus on breast cancer and

Read More

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 2:11 AM

Gainers

Read More

2 minute read

FDA
News

Atossa Therapeutics Begins Enrollment In Clinical Study Of AT-H201 In Australia

By Benzinga Newsdesk

Today, 2:11 AM

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with

Read More

1 minute read

Atossa Therapeutics Shares See Volume; Traders Circulate SeekingAlpha Article ‘Atossa Therapeutics Is A Takeover Target Worth Triple It’s Current Stock Price.’

By Benzinga Newsdesk

Today, 2:11 AM

https://seekingalpha.com/instablog/51307855-tradeinvestments2019/5640574-atossa-therapeutics-is-takeover-target-worth-triple-current-stock-price

Read More

1 minute read

Trading Ideas

‘3 Reasons to Love Atossa Therapeutics Stock’ -TipRanks

By Michael Horton

Today, 2:11 AM

https://www.tipranks.com/news/article/3-reasons-to-love-atossa-therapeutics-stock/

Read More

2 minute read

News

Atossa Therapeutics Adjourns Special Stockholder Meeting To October 7, 2021 To Allow Additional Time To Vote

By Benzinga Newsdesk

Today, 2:11 AM

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with

Read More

1 minute read

Atossa To Conduct Endoxifen Mid-Stage Study In Sweden

By Vandana Singh

Today, 2:11 AM

Atossa Therapeutics Inc (NASDAQ:ATOS) has received approval from the Swedish Ethics Review Authority to begin a Phase 2 clinical study of…

Read More

2 minute read

Atossa Therapeutics Reports Approval From Swedish Ethics Review Authority To Initiate Phase 2 Study Of Oral Endoxifen To Reduce Mammographic Breast Density

By Benzinga Newsdesk

Today, 2:11 AM

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with

Read More

1 minute read

Atossa Genetics Shares Spike Higher On Volume, Now Up 3%; Traders Circulate TipRanks Article ‘Atossa: Strong Balance Sheet Will Support the Pipeline’s Advance, Says Analyst’

By Benzinga Newsdesk

Today, 2:11 AM

https://blog.tipranks.com/atossa-strong-balance-sheet-will-support-the-pipelines-advance-says-analyst/